Kvopka Michael, Smith Justine R, Koczwara Bogda, Lake Stewart R
Ophthalmology Unit, Division of Surgery, Flinders Medical Centre, Adelaide, Australia.
Eye & Vision Health, Flinders University College of Medicine and Public Health, Flinders Medical Centre Room, Flinders Drive, Bedford Park, SA, 5042, Australia.
Int J Retina Vitreous. 2022 Sep 6;8(1):63. doi: 10.1186/s40942-022-00415-y.
To report a case of bilateral intermediate uveitis without cystoid macular edema secondary to paclitaxel therapy, and its successful management with oral corticosteroids.
A 66-year-old female developed bilateral intermediate uveitis with reduced best corrected visual acuity to 20/40 right and 20/200 left, following 12 cycles of paclitaxel therapy for breast carcinoma. Optical coherence tomography demonstrated no cystoid macular edema in either eye, and fundus fluorescein angiography showed localized retinal vascular leakage. Resolution of uveitis and improvement of visual acuity followed treatment with oral prednisolone for two months. Fourteen months after presentation, right and left visual acuities had returned to 20/32 and 20/40, respectively, and there was no recurrence of the uveitis.
This is the first reported case of bilateral intermediate uveitis in a patient treated with paclitaxel. Drug-induced uveitis should be considered in patients with visual symptoms in the setting of taxane chemotherapy, and oral corticosteroids are a safe and effective treatment.
报告一例紫杉醇治疗继发的无黄斑囊样水肿的双侧中间葡萄膜炎病例,以及口服糖皮质激素对其的成功治疗。
一名66岁女性在接受12周期紫杉醇治疗乳腺癌后,出现双侧中间葡萄膜炎,最佳矫正视力降至右眼20/40,左眼20/200。光学相干断层扫描显示双眼均无黄斑囊样水肿,眼底荧光血管造影显示视网膜局部血管渗漏。口服泼尼松龙治疗两个月后葡萄膜炎消退,视力改善。就诊14个月后,右眼和左眼视力分别恢复至20/32和20/40,葡萄膜炎未复发。
这是首例报道的接受紫杉醇治疗患者发生的双侧中间葡萄膜炎病例。在紫杉烷化疗背景下出现视觉症状的患者应考虑药物性葡萄膜炎,口服糖皮质激素是一种安全有效的治疗方法。